Skip to Main Content
Home
Search
Study Topics
Glossary
Full Text View
Tabular View
No Study Results Posted
Related Studies
Antibiotic Therapy and Antacids in Patients With Malt Lymphoma of the Stomach
This study is ongoing, but not recruiting participants.
Study NCT00002682 Information provided by National Cancer Institute (NCI)
First Received: November 1, 1999 Last Updated: November 16, 2008
History of Changes
Related Studies can be found by searching for the Conditions, Interventions, and Sponsors found in this study:
Conditions listed in this trial
Lymphoma
Additional conditions recognized in this trial
Lymphoma, B-Cell, Marginal Zone
More general conditions related to this trial
Immune System Diseases
Immunoproliferative Disorders
Lymphatic Diseases
Lymphoma, B-Cell
Lymphoma, Non-Hodgkin
Lymphoproliferative Disorders
Neoplasms
Neoplasms by Histologic Type
Interventions listed in this trial
amoxicillin
bismuth subsalicylate
clarithromycin
metronidazole hydrochloride
omeprazole
tetracycline hydrochloride
Additional drug interventions recognized in this trial
Anti-Bacterial Agents
Metronidazole
Tetracycline
More general drug interventions related to this trial
Anti-Infective Agents
Anti-Ulcer Agents
Antidiarrheals
Antiparasitic Agents
Antiprotozoal Agents
Enzyme Inhibitors
Gastrointestinal Agents
Molecular Mechanisms of Pharmacological Action
Pharmacologic Actions
Physiological Effects of Drugs
Protein Synthesis Inhibitors
Radiation-Sensitizing Agents
Therapeutic Uses
Sponsors listed in this trial
M.D. Anderson Cancer Center
National Cancer Institute (NCI)
Back to top of Main Content
